This website your browser does not support. Please upgrade your browser Or Use google Crome
';
Latest Announcments
Other Links
Major outcomes include the following
Vaccines developed / leads obtained Diagnostics developed / leads obtained
Three vaccine candidates for Classical Swine Fever are available Recombinant Erns antigen based agglutination assay for CSF
Heat killed chitosan coupled Mycobacterium avium subsp. Paratuberclosis vaccine for small ruminants and cattle An ELISA based diagnostic test for PPR was developed and the technology was transferred to Indian Immunologicals Ltd., Hyderabad for commercialization.
Gene deletion mutant marker vaccine for Bovine herpes virus I A nested PCR assay for detection and identification for bovine mycobacterial strains
Recombinant VP2 protein based sub unit vaccine against IBD in poultry A novel PCR based diagnostic for rapid diagnosis of buffalo pox virus
Biomarker coupled nano-NewCastle disease virus vaccine Recombinant phage display antibodies against nucleoprotein of avian influenza virus
Inactivated tissue culture vaccine for IBR that was transferred to industry and vaccine is available in the market.
A technology for production of recombinant Anthrax Vaccine was developed and transferred to M/s Panacea Biotech Ltd. Phase I/II human clinical trial studies have been completed.
An attenuated buffalo pox virus vaccine
Recombinant vaccine against Haemorrhagic Septicaemia
Self Replicating DNA vaccine
Recombinant vaccine for Theileria annulata
Biofilm based vaccine against mastitis pathogens, Staphylococcus aureus and Escherichia coli